Berkshire Hathaway Is Sitting on a Record $397 Billion in Cash. Is the Stock a Buy in the Greg Abel Era?

Summary

Article discusses Berkshire Hathaway's record $397 billion cash position and explores investment considerations in the Greg Abel era. This is not biotech/pharmaceutical news and contains no clinical, regulatory, or product-specific information.